New executive appointment at Elan
This article was originally published in Scrip
Executive Summary
Elan has named Dr Eliseo Oreste Salinas executive vice-president and chief medical officer, with responsibility for leading the company's development, clinical and medical initiatives. He will be based at the company's South San Francisco campus and will report to its president, Dr Carlos Paya. As chief medical officer, he will also retain specific accountabilities to the Elan's CEO, Kelly Martin, relating to patient safety. Dr Salinas joins from Adolor, where he was senior vice-president of R&D and chief medical officer. Before that, he was at Shire, where he worked as chief scientific officer and executive vice-president of global pharmaceutical R&D. Elan's current chief medical officer and head of development, Dr Menghis Bairu, will resume his primary responsibility as executive vice-president and general manager of Tysabri.